Souders Financial Advisors’s Gilead Sciences GILD Stock Holding History

Souders Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$552K	Buy	3,963 +714	+22%	+$100K	0.06%	135
2025 Q4	$399K	Buy	3,249 +269	+9%	+$32.7K	0.05%	154
2025 Q3	$331K	Sell	2,980 -504	-14%	-$57.3K	0.04%	169
2025 Q2	$386K	Buy	3,484 +771	+28%	+$82.1K	0.05%	145
2025 Q1	$304K	Buy	+2,713	New	+$280K	0.04%	155
2022 Q1	–	Sell	-39,151	Closed	-$2.84M	–	149
2021 Q4	$2.84M	Buy	39,151 +895	+2%	+$61.6K	0.82%	42
2021 Q3	$2.67M	Buy	38,256 +567	+2%	+$39.8K	0.86%	41
2021 Q2	$2.6M	Buy	37,689 +557	+2%	+$37.2K	0.87%	40
2021 Q1	$2.4M	Sell	37,132 -4,844	-12%	-$312K	0.94%	36
2020 Q4	$2.45M	Sell	41,976 -505	-1%	-$30.5K	1.07%	29
2020 Q3	$2.58M	Buy	42,481 +21,835	+106%	+$1.51M	1.22%	25
2020 Q2	$1.59M	Sell	20,646 -10,482	-34%	-$803K	0.91%	39
2020 Q1	$2.33M	Buy	+31,128	New	+$2.15M	2.05%	11

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Souders Financial Advisors's GILD Position: Q1 2026 in Review

Souders Financial Advisors increased its Gilead Sciences (GILD) stake by 22% in Q1 2026, buying an estimated $100K and bringing the position to 3,963 shares worth $552K. The position accounts for 0.06% of the portfolio, ranked #135.

Souders Financial Advisors first reported a position in GILD in Q1 2020 and has held it in 13 quarters since. The position peaked at $2.84M in Q4 2021. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Souders Financial Advisors held 3,963 shares of Gilead Sciences worth $552K as of Q1 2026.
Souders Financial Advisors bought 714 Gilead Sciences shares in Q1 2026, an estimated $100K.
Gilead Sciences made up 0.06% of Souders Financial Advisors's portfolio in Q1 2026, its #135 holding.
Souders Financial Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 13 quarters since.
Souders Financial Advisors's Gilead Sciences position peaked at $2.84M in Q4 2021.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Souders Financial Advisors's 13F filing for Q1 2026, filed 4 May 2026.